Abstract:Background: Major advances have been made in stroke treatment and prevention in the past decades. However, the burden of stroke remains high. Identification of novel targets and establishment of effective interventions to improve stroke outcomes are, therefore, needed. Recent research highlights the contribution of the gut microbiota to stroke pathogenesis. Summary: Compositional and functional alterations of the gut microbiota, termed dysbiosis, are linked to stroke risk factors, such as obesity, metabolic diseases, and atherosclerosis. In acute cerebral ischemia, the gut microbiota plays a key role in bidirectional interactions between the gut and brain, referred to as the microbiota-gut-brain axis. Gut dysbiosis prior to ischemic stroke affects outcomes. Additionally, the brain affects the gut microbiota during acute ischemic brain injury, which in turn impacts outcomes. Interactions between the gut microbiota and stroke pathogenesis are mediated by several factors including bacterial components (e.g., lipopolysaccharide), gut microbiota-related metabolites (e.g., short-chain fatty acids and trimethylamine N-oxide), and the immune and nervous systems. Clinical studies have reported that patients with acute ischemic stroke exhibit gut dysbiosis, which is associated with host metabolism and inflammation, as well as functional outcomes. Modulation of the gut microbiota or its metabolites improves conditions related to stroke pathogenesis, including inflammation, cardiometabolic disease, atherosclerosis, and thrombosis. Key Messages: Accumulating evidence indicates that the gut microbiota plays a possible role in stroke pathogenesis. Modulation of the gut microbiota may provide a novel therapeutic strategy for the treatment and prevention of stroke.

The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke

Gut Microbiota-Mediated Ursodeoxycholic Acids Regulate the Inflammation of Microglia Through TGR5 Signaling after MCAO.

Crosstalk between the Gut and Brain in Ischemic Stroke: Mechanistic Insights and Therapeutic Options

Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions

Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?

Role of the gut microbiota in complications after ischemic stroke

Gut-brain axis: Mechanisms and potential therapeutic strategies for ischemic stroke through immune functions

The interaction between intestinal microenvironment and stroke

From Gut to Brain: Unraveling the Intricate Link Between Microbiome and Stroke

Bidirectional Gut-Brain-microbiota Axis As a Potential Link Between Inflammatory Bowel Disease and Ischemic Stroke

Role of the Gut Microbiota in Stroke Pathogenesis and Potential Therapeutic Implications

Ischemic stroke and intestinal flora: an insight into brain–gut axis

Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites

Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota

The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke

Role of Gut Microbiota in Ischemic Stroke: A Narrative Review of Human and Animal Studies

How Brain Infarction Links With the Microbiota–Gut–Brain Axis: Hints From Studies Focusing on the Risk Factors for Ischemic Stroke

Microbiota Metabolites and Immune Regulation Affect Ischemic Stroke Occurrence, Development, and Prognosis

A potential role of gut microbiota in stroke: mechanisms, therapeutic strategies and future prospective

New Insights into Stroke Prevention and Treatment: Gut Microbiome

Exploratory Investigation Of Intestinal Structure And Function After Stroke In Mice